Hi Agent -86 and Harry58
I saw the news article too - it was suggested that it may extend life.
If VAXinia gets more CRs, PRs and SDs, for bile duct cancer and others in ongoing and future trials, AstraZeneca’s product might be less beneficial - which might pique their interest in IMU.
Glad that their product is potentially providing a benefit - hoping that VAXinia will provide an even greater benefit to sufferers.
Go Imugene!
PDS
Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program, page-410
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |